Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of bowel preparation regimens for colonoscopy: PEG-Asc vs PEG-Asc + bisacodyl vs PEG-Asc + coffee
TCTR20170512001Phase 3Completed
- Sponsor
- The Faculty of Medicine Endowment Fund
- Start
- Jun 2017
- Modality
- Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Non-biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3 trial of macrogol, ascorbic acid and bisacodyl (3 arms), sponsored by The Faculty of Medicine Endowment Fund. Primary endpoint: Quality of bowel preparation. Started Jun 2017; status: completed.
02
Drugs
macrogolascorbic acidbisacodyl
Beyond the preview
Go deeper on TCTR20170512001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20170512001.